Disclosures for "Use of individual measure and Z-scores to monitor disease course in Relapsing Multiple Sclerosis: A 1-year Prospective Study in a Single Center")
-
Mr. Solís-Tarazona has received personal compensation for serving as an employee of Novo Nordisk A/S. Mr. Solís-Tarazona has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for UCB Pharma Spain.
-
Salma Reddam has nothing to disclose.
-
Dr. Gil-Perotin has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.